PCN106 A Study to Assess the Impact of Incorporating the ‘Probability of Being in Response Function’ into an Economic Model for Nivolumab in Advanced Renal-Cell Carcinoma
Dec 1, 2020, 00:00 AM
10.1016/j.jval.2020.08.243
https://www.valueinhealthjournal.com/article/S1098-3015(20)32499-2/fulltext
Section Title :
Section Order :
10191
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32499-2&doi=10.1016/j.jval.2020.08.243